• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改进用于估算低密度脂蛋白胆固醇水平的Martin-Hopkins方法:中位数与最佳甘油三酯/极低密度脂蛋白胆固醇比值

Refining the Martin-Hopkins method for estimating low-density lipoprotein cholesterol levels: Median versus optimal TG/VLDL-C ratio.

作者信息

Lee Jongseok, Lee Hyelim, Cha Hwajung, Seok Jun, Jeong In Cheol

机构信息

School of Artificial Intelligence Convergence, Hallym University, Chuncheon, Republic of Korea.

College of Medicine, Hallym University, Chuncheon, Republic of Korea.

出版信息

PLoS One. 2025 Jul 3;20(7):e0327169. doi: 10.1371/journal.pone.0327169. eCollection 2025.

DOI:10.1371/journal.pone.0327169
PMID:40608775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12225850/
Abstract

BACKGROUND

Low-density lipoprotein cholesterol (LDL-C), a major modifiable risk factor for cardiovascular diseases, is typically calculated using the Friedewald formula when triglyceride (TG) levels are below 400 mg/dL. Recent studies have demonstrated the superior accuracy of the Martin-Hopkins method across diverse populations. While this method estimates very-low-density lipoprotein cholesterol (VLDL-C) using strata-specific median TG/VLDL-C ratios, its reliance on median statistics raises questions about whether these ratios are truly optimal.

OBJECTIVES AND METHODS

This study evaluated the performance of the Martin-Hopkins method compared to the Friedewald formula, focusing on its potential for improvement by applying optimal TG/VLDL-C ratios. Using data from 18,322 individuals in the Korea National Health and Nutrition Examination Survey (KNHANES), we derived strata-specific optimal TG/VLDL-C ratios designed to maximize concordance with directly measured LDL-C values, based on LDL-C categories defined by clinical guidelines. We compared the performance of four LDL-C estimation models: the Friedewald formula (LDL-CF), the original Martin-Hopkins method (LDL-CM-N), and two alternative models that applied TG/VLDL-C ratios derived from our data-one using median values (LDL-CKM-N) and the other using optimal values tailored to each stratum (LDL-CKO-N).

RESULTS

The Martin-Hopkins method showed significantly higher concordance than the Friedewald formula for TG levels < 400 mg/dL (79.6% for LDL-CF vs. 83.2% for LDL-CM-180, p < 0.001). Concordance improved by less than 2% for TG levels < 150 mg/dL (83.3% vs. 84.9%), but by approximately 10% for TG levels of 150-399 mg/dL (68.8% vs. 78.0%). The largest discrepancy was observed in classifying LDL-C levels < 70 mg/dL among individuals with TG levels of 150-399 mg/dL (47.5% for LDL-CF vs. 90.3% for LDL-CM-180). However, the overall concordance differed only modestly between the 10-cell and 180-cell Martin-Hopkins equations (82.8% for LDL-CM-10 vs. 83.2% for LDL-CM-180, a difference of 0.4%), indicating only a marginal benefit despite the substantial increase in the number of strata. Using optimal TG/VLDL-C ratios increased overall concordance compared to median ratios within the same stratification, with LDL-CKO-N estimates outperforming their LDL-CKM-N counterparts. However, this improvement was not statistically significant in LDL-C estimates derived from TG-only stratification.

CONCLUSIONS

Applying optimal TG/VLDL-C ratios within the Martin-Hopkins method improves accuracy compared to median ratios, particularly when stratifications incorporate both TG and non-high-density lipoprotein cholesterol (non-HDL-C) levels. This enhancement can be achieved without increasing the number of strata, offering a practical pathway to refine LDL-C estimation while avoiding excessive stratification. Our findings suggest that while median statistics may be sufficient for TG-only stratifications, they do not fully capture optimal TG/VLDL-C ratios for combined TG and non-HDL-C stratifications.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/8c3d1e58f41d/pone.0327169.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/9d7adeeed472/pone.0327169.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/ba48de9fa8d3/pone.0327169.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/140eb5bdfb51/pone.0327169.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/d02971bcee2d/pone.0327169.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/5709fd8109e7/pone.0327169.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/6686b4b3ec21/pone.0327169.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/8c3d1e58f41d/pone.0327169.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/9d7adeeed472/pone.0327169.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/ba48de9fa8d3/pone.0327169.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/140eb5bdfb51/pone.0327169.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/d02971bcee2d/pone.0327169.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/5709fd8109e7/pone.0327169.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/6686b4b3ec21/pone.0327169.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29d/12225850/8c3d1e58f41d/pone.0327169.g007.jpg
摘要

背景

低密度脂蛋白胆固醇(LDL-C)是心血管疾病的主要可改变风险因素,当甘油三酯(TG)水平低于400mg/dL时,通常使用Friedewald公式计算。最近的研究表明,Martin-Hopkins方法在不同人群中具有更高的准确性。虽然该方法使用特定分层的TG/VLDL-C中位数比率来估计极低密度脂蛋白胆固醇(VLDL-C),但其对中位数统计的依赖引发了这些比率是否真正最优的问题。

目的和方法

本研究评估了Martin-Hopkins方法与Friedewald公式相比的性能,重点关注通过应用最优TG/VLDL-C比率进行改进的潜力。利用韩国国家健康与营养检查调查(KNHANES)中18322名个体的数据,我们根据临床指南定义的LDL-C类别,得出了旨在使与直接测量的LDL-C值的一致性最大化的特定分层最优TG/VLDL-C比率。我们比较了四种LDL-C估计模型的性能:Friedewald公式(LDL-CF)、原始的Martin-Hopkins方法(LDL-CM-N)以及两种应用我们数据得出的TG/VLDL-C比率的替代模型——一种使用中位数(LDL-CKM-N),另一种使用针对每个分层量身定制的最优值(LDL-CKO-N)。

结果

对于TG水平<400mg/dL,Martin-Hopkins方法显示出比Friedewald公式显著更高的一致性(LDL-CF为79.6%,LDL-CM-180为83.2%,p<0.001)。对于TG水平<150mg/dL,一致性提高不到2%(83.3%对84.9%),但对于TG水平为150 - 399mg/dL,一致性提高了约10%(68.8%对78.0%)。在TG水平为150 - 399mg/dL的个体中,对LDL-C水平<70mg/dL进行分类时观察到最大差异(LDL-CF为47.5%,LDL-CM-180为90.3%)。然而,10单元格和180单元格的Martin-Hopkins方程之间的总体一致性差异不大(LDL-CM-10为82.8%,LDL-CM-180为83.2%,差异为0.4%),表明尽管分层数量大幅增加,但仅带来了边际益处。与相同分层内的中位数比率相比,使用最优TG/VLDL-C比率可提高总体一致性,LDL-CKO-N估计优于其LDL-CKM-N对应项。然而,在仅基于TG分层得出的LDL-C估计中,这种改进在统计学上并不显著。

结论

与中位数比率相比,在Martin-Hopkins方法中应用最优TG/VLDL-C比率可提高准确性,特别是当分层同时纳入TG和非高密度脂蛋白胆固醇(non-HDL-C)水平时。这种改进可以在不增加分层数量的情况下实现,为优化LDL-C估计提供了一条实用途径,同时避免过度分层。我们的研究结果表明,虽然中位数统计对于仅基于TG的分层可能足够,但它们不能完全捕捉到TG和non-HDL-C联合分层的最优TG/VLDL-C比率。

相似文献

1
Refining the Martin-Hopkins method for estimating low-density lipoprotein cholesterol levels: Median versus optimal TG/VLDL-C ratio.改进用于估算低密度脂蛋白胆固醇水平的Martin-Hopkins方法:中位数与最佳甘油三酯/极低密度脂蛋白胆固醇比值
PLoS One. 2025 Jul 3;20(7):e0327169. doi: 10.1371/journal.pone.0327169. eCollection 2025.
2
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination Survey, 2009-2011.韩国成年人中马丁法估算低密度脂蛋白胆固醇水平的验证:来自2009 - 2011年韩国国家健康与营养检查调查的结果
PLoS One. 2016 Jan 29;11(1):e0148147. doi: 10.1371/journal.pone.0148147. eCollection 2016.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.马丁/霍普金斯估计、弗里德瓦尔德估计和制备超速离心法评估低密度脂蛋白胆固醇的比较: FOURIER 试验的见解。
JAMA Cardiol. 2018 Aug 1;3(8):749-753. doi: 10.1001/jamacardio.2018.1533.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
10
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.

本文引用的文献

1
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients.23 个在包含 5,051,467 名患者的临床实验室数据库中估算 LDL 胆固醇的方程的准确性。
Glob Heart. 2023 Jun 19;18(1):36. doi: 10.5334/gh.1214. eCollection 2023.
2
Comparison of Three Methods for LDLC Calculation for Cardiovascular Disease Risk Categorisation in Three Distinct Patient Populations.比较三种方法计算三种不同患者人群心血管疾病风险分类中的 LDL-C。
Can J Cardiol. 2023 May;39(5):668-677. doi: 10.1016/j.cjca.2022.12.025. Epub 2022 Dec 28.
3
Comparability of calculated LDL-C with directly measured LDL-C in selected paediatric and adult cohorts.
在选定的儿科和成人队列中,计算 LDL-C 与直接测量 LDL-C 的可比性。
Clin Chim Acta. 2022 Dec 1;537:158-166. doi: 10.1016/j.cca.2022.10.003. Epub 2022 Oct 18.
4
Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.验证 Friedewald、Martin-Hopkins 和 Sampson 低密度脂蛋白胆固醇方程。
PLoS One. 2022 May 13;17(5):e0263860. doi: 10.1371/journal.pone.0263860. eCollection 2022.
5
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.比较高甘油三酯血症患者估算低密度脂蛋白胆固醇的方法。
JAMA Netw Open. 2021 Oct 1;4(10):e2128817. doi: 10.1001/jamanetworkopen.2021.28817.
6
Comparison of the effectiveness of Martin's equation, Friedewald's equation, and a Novel equation in low-density lipoprotein cholesterol estimation.马丁方程、弗里德瓦尔德方程和新型方程在低密度脂蛋白胆固醇估算中的效果比较。
Sci Rep. 2021 Jun 29;11(1):13545. doi: 10.1038/s41598-021-92625-x.
7
Measuring LDL-cholesterol: what is the best way to do it?测量 LDL-胆固醇:哪种方法最好?
Curr Opin Cardiol. 2020 Jul;35(4):405-411. doi: 10.1097/HCO.0000000000000740.
8
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia.载脂蛋白 B 正常或高甘油三酯血症患者计算低密度脂蛋白胆固醇的新方程。
JAMA Cardiol. 2020 May 1;5(5):540-548. doi: 10.1001/jamacardio.2020.0013.
9
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会/美国心血管和肺康复协会/美国医师助理学会/美国心脏协会心血管病理事会/美国预防医学学院/美国糖尿病协会/美国老年医学会/美国药剂师协会/美国医学主任协会/美国国家脂质协会/美国初级保健医师学会血液胆固醇管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Jun 18;139(25):e1046-e1081. doi: 10.1161/CIR.0000000000000624. Epub 2018 Nov 10.
10
Validation of the Friedewald formula for estimating low density lipoprotein cholesterol: the Korea National Health and Nutrition Examination Survey, 2009 to 2011.验证 Friedewald 公式估算低密度脂蛋白胆固醇的准确性:2009 至 2011 年韩国国家健康和营养检查调查。
Korean J Intern Med. 2020 Jan;35(1):150-159. doi: 10.3904/kjim.2017.233. Epub 2018 Mar 21.